FINAL PROGRAM
February 5-8, 2026
Grand Hyatt Deer Valley Park City, Utah
Dear Colleagues,
We are thrilled to welcome you to Park City, Utah, and to the 2026 Joint Arthroplasty Mountain Meeting® (JAMM®) presented in partnership by The Hip Society and The Knee Society.
Whether you have attended previous JAMM® courses, or you decided to try it out for the first time, we are sure you will enjoy your time with us and will leave the course armed with new knowledge, current updates, and valuable connections. What makes JAMM® unique is its robust academic program that is a dynamic blend of didactics, case-based learning, videos, and debates – all presented in a roundtable format to facilitate active participant-faculty interaction. It is our goal to keep the program fresh, fast-paced and stimulating, while allowing ample time for questions and table-side discussions.
A plethora of timely hip and knee arthroplasty topics will be presented by our outstanding faculty of experts, most of whom are members of The Hip Society and The Knee Society. We also encourage you to participate in industry-led sessions to add value to your overall experience.
JAMM® is intentionally informal and fun. You will get the most out of it if you engage in dialogue and discussions with your peers and our faculty. Join us on Thursday evening for a Welcome Reception to meet everyone, to connect, and to embark on a 3-day learning adventure.
Thank you for attending!
JAMM® 2026 FACULTY
John Antoniou, MD, PhD
SMBD - Jewish General Hospital Montreal, QC, Canada
Michael J. Archibeck, MD University of Utah Salt Lake CIty, UT
Matthew S. Austin, MD Hospital for Special Surgery New York, NY
Henry D. Clarke, MD Mayo Clinic Phoenix, AZ
P. Maxwell Courtney, MD Rothman Institute Philadelphia, PA
Fred D. Cushner, MD Hospital for Special Surgery New York, NY
Ronald E. Delanois, MD University of Maryland Baltimore, MD
Christopher A. F. Dodd, FRCS Nuffield Health, The Manor Hospital Oxford Oxford, United Kingdom
Elizabeth B. Gausden, MD, MPH Hospital for Special Surgery New York, NY
Jeremy M. Gililland, MD University of Utah Salt Lake City, UT
George J. Haidukewych, MD Orlando Health Orthopaedic Institute Orlando, FL
Aaron A. Hofmann, MD Hofmann Arthritis Institute Salt Lake City, UT
James L. Howard, MD, MSc, FRCSC London Health Sciences Centre London, ON, Canada
Cynthia A. Kahlenberg, MD, MPH Hospital for Special Surgery New York, NY
Ormonde M. Mahoney, MD
Athens Orthopaedic Clinic Athens, GA
David C. Markel, MD The CORE Institute Novi, MI
David J. Mayman, MD Hospital for Special Surgery New York, NY
Richard W. McCalden, MD
London Health Sciences Centre London, ON, Canada
Douglas D.R. Naudie, MD
London Health Sciences Centre London, ON, Canada
Mark W. Pagnano, MD Mayo Clinic Rochester, MN
Wayne G. Paprosky, MD Midwest Orthopaedics at RUSH Westchester, IL
Christopher E. Pelt, MD University of Utah Salt Lake City, UT
Christopher L. Peters, MD University of Utah Salt Lake, UT
Edward M. Vasarhelyi, MD
London Health Sciences Centre London, ON, Canada
Samuel S. Wellman, MD Duke University Durham, NC
Geoffrey H. Westrich, MD Hospital for Special Surgery New York, NY
Ran Schwarzkopf, MD, MSc New York University, NYU Langone Medical Center New York, NY
Roshan P. Shah, MD, JD Columbia University Medical Center New York, NY
Neil P. Sheth, MD University of Pennsylvania Philadelphia, PA
James D. Slover, MD, MS Northwell Lenox Hill Hospital New York, NY
Eric L. Smith, MD New England Baptist Hospital Boston, MA
Mark J. Spangehl, MD Mayo Clinic Scottsdale, AZ
Michael J. Taunton, MD Mayo Clinic Rochester, MN
JAMM® 2026 Faculty Disclosure of Relevant Financial Relationships as
AAll individuals in a position to influence and/or control the content of AO North America (AO NA) CME activities are required to disclose to AO NA and subsequently to learners that the individual either has no financial relationships or any financial relationships with ineligible companies. An ineligible company is defined as any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. All of the relevant financial relationships listed for these individuals have been mitigated.
Michael J. Archibeck MD, has disclosed that he receives salary/benefits from Zimmer Biomet
Henry D. Clarke, MD, has disclosed that he receives royalties as a consultant for Zimmer Biomet and receives royalties as a consultant for Restor3D/ConforMIS
P. Maxwell Courtney, MD, has disclosed that he receives consulting fees as a consultant for Zimmer.
Christopher A. F. Dodd, FRCS, has disclosed that he is a paid consultant, presenter or speaker for and receives IP royalties from Zimmer Biomet.
Elizabeth B. Gausden, MD, MPH, has disclosed she receives consulting fees as a consultant for DePuy.
Jeremy M. Gililland, MD, has disclosed that he receives consulting fees/royalties from Enovis, MiCare Path, Stryker and Zimmer Biomet; and he receives equity as an investor in MiCare Path, Sylke, Connextions, OR Innovations and Solenic Medical.
George J. Haidukewych, MD, has disclosed he receives royalties from DePuy Synthes and Zimmer Biomet as an inventor; consulting fees from Smith & Nephew as a consultant; and stock as a consultant for Solenic.
James L. Howard, MD, MSc, FRCSC, has disclosed that he is a paid consultant, presenter or speaker for DePuy, A Johnson & Johnson Company, Intellijoint, Sanofi-Aventis, Smith & Nephew, Stryker and Zimmer; he receives research support from Depuy, A Johnson & Johnson Company; and receives other financial or material support from DePuy, A Johnson & Johnson Company, Microport, Stryker and Zimmer.
Cynthia Kahlenberg, MD, had disclosed that she has professional activities with smith and Nephew
Ormonde M. Mahoney, MD, has disclosed that he receives IP royalties and research support and is a paid consultant for Stryker; he is also an unpaid consultant for Surgical Devices, Inc.
David J. Mayman, MD, has disclosed he receives consulting fees and royalties as a consultant and inventor from Stryker; he receives royalties as an inventor for Smith & Nephew and Orthoalign; and receives stock options as an inventor for Cymedica, IMagen, MiCare Path, Wishbone, and Ortho AI.
Douglas D.R. Naudie, MD, discloses he receives honoraria and royalites as a consultant from Smith & Nephew
Mark W. Pagnano, MD, has disclosed he receives IP royalties as a consultant for DePuy/Johnson & Johnson
Wayne G. Paprosky, MD, FACS, has disclosed that he receives royalties as a consultant for Zimmer and Medacta and as an author for Springer-Verla; he receives stock as a consultant for Intellijoint.
Christopher E. Pelt, MD, has disclosed that he receives consulting fees, royalties and stock options as a consultant, member of Medical Advisory Board and Speaker's Bureau for Total Joint Orthopedics; he receives research support as Principal Investigator from Zimmer Biomet and Peptilogics; he receives consulting fees as a consultant for Smith & Nephew; he receives stocks as an investor in Joint Development; and receives consulting fees and travel expenses as a consultant for Solventum. 3
JAMM® 2026 Faculty Disclosure of Relevant Financial Relationships
Ran Schwarzkopf, MD, MSc, has disclosed he receives consulting fees as a consultant for Intellijoint Surgical, Smith & Nephew, and Zimmer Biomet; and he receives equity as a Board member for Parvizi Surgical Innovation.
Roshan P. Shah, MD, has disclosed he has professional activities with Zimmer Biomet Holdings, Inc.
James D. Slover, MD, MS, has disclosed he owns stock in Abbott Labs, AbbVie, Bio Rad Labs, Charles River Labs, Con MEd Corp, Conoco Phillips, Eastman Chemical, Hologic, Illumina, Intuitive Surgical, Johnson & Johnson, Kenvue, McKesson, Myriad Genetics, Novartis, Pfizer, Oragenics, Regeneron. Roche, Thermo Fisher, and Vertex.
Eric L. Smith, MD, has disclosed he receives honoraria as a Consultant for DePuy Synthes
Michael J. Taunton, MD, has disclosed he receives royalties, consulting fees, and travel expenses for consulting and intellectural property from DJ Ortho Inc.
Edward M. Vasarhelyi, MD, has disclosed he receives honorarium for consulting and private investigator for Johnson & Johnson MedTech.
Samuel Wellman, MD, has disclosed he receives consulting fees and travel expenses as a consultant for Total Joint Orthopedics; he receives research support as a Principal Investigator for DePuy Synthes, Medacta, Smith & Nephew, Stryker and Zimmer; and receives speaking fees from serving on the Speaker’s Bureaus for Stryker and Zimmer.
The following faculty and planners have no relevant financial relationships with ineligible companies to disclose:
Matthew Austin, MD
John Antoniou, MD, PhD
Robert L. Barrack, MD
Fred D. Cushner, MD
Ronald E. Delanois, MD
David C. Markel, MD
Richard W. McCalden, MD
Neil P. Sheth, MD
Mark J. Spangehl, MD
Geoffrey H. Westrich, MD
Cynthia Diaz (Planner)
Jola Tricroce (Planner)
GENERAL INFORMATION
REGISTRATION
ABOUT THE HIP SOCIETY
www.hipsoc.org
The Hip Society was established in 1968, by Frank Stinchfield, MD, as a by-invitation only academic society together with twenty elite hip surgeons. The mission of The Hip Society is to advance the knowledge and treatment of hip disorders to improve the lives of our patients.
ABOUT THE KNEE SOCIETY
www.kneesociety.org
The Knee Society was established in 1983, as a forum for intellectual exchange of concepts in total knee arthroplasty. The main initial goal of the founding group was to bring together the scientific information related to total knee arthroplasty. The mission of The Knee Society is to promote outstanding care to patients with knee disorders through innovative research and education.
As a pre-registered attendee, you will be receiving a hard copy of the Daily Schedule and a link to the Final Program and handouts. We will not be distributing any printed handouts for this course.
CME ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AO North America, Inc.® (AONA) and The Hip Society and The Knee Society. AO North America, Inc.® (AONA) is accredited by the ACCME to provide continuing medical education for physicians.
The AO North America, Inc. designates this live educational activity for a maximum of 16 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
If you need to request a copy of the CME Certificate, or have any questions, please email hip@hip-knee.org
COURSE OBJECTIVES
The Course Objectives for Joint Arthroplasty Mountain Meeting® (JAMM®) are:
Learn techniques of hip and knee revision arthroplasty.
Develop an enhanced understanding of the knee alignment conundrum.
Learn about the increase rise in the number of cementless total knee arthroplasty performed today.
Recognize the compartmental approach to knee arthroplasty.
Learn how distinguished faculty cared for their patients via case presentations.
LOCATION
All events will take place in Grand Hyatt Deer Park, Jordanelle Ballrooms and Deer Park Ballrooms.
SEATING BADGES
Valid badges are required for everyone entering the JAMM® designated meeting space, participating in educational events, and partaking of the food and beverage functions. This includes guests of all ages. This policy will be strictly enforced.
JAMM® experience is built upon a round-table format, with ample time for discussions and interactions. Your badge will have a number corresponding to the table you’ve been assigned to. Please stay at your table for the duration of the course. We will rotate faculty, so you will benefit from different views and teaching styles.
EXHIBITS
Please give our exhibitors and sponsors the time and attention they deserve. Visit all exhibitors to learn about their product, services, and the latest technology.
PHOTOGRAPHY
Photographs and videos of JAMM® 2026 will be taken throughout the program by authorized staff. By registering for, and attending the events scheduled within the framework of the meeting, participants and their guests agree that their image and name may be used by The Hip Society and The Knee Society in electronic and print promotional materials and other professional communications including web-based publications, without payment or other consideration.
EVALUATION
CLICK HERE TO SUBMIT YOUR COURSE EVALUATION
If you are active on social media, post photos or videos and use: #JAMM #JAMM2026 #ElevateYourLearning
INDUSTRY SPOTLIGHT SESSIONS (NON-CME)
THURSDAY, FEBRUARY 5 | 5:10 - 5:55 PM
Disease State Education on Desmoid Tumors
Presented by
SPEAKERS: Christopher A. F. Dodd, MD
THURSDAY, FEBRUARY 5 | 6:35 - 7:00 PM
Presented by Oxford Cementless – 50 years of Excellence
SPEAKERS: Fred D. Cushner, MD, George J. Haidukewych, MD, David C. Markel, MD
FRIDAY, FEBRUARY 6 | 8:20 - 8:45 AM
The Robotic Knee Revolution + DA360: Personalized Solutions for Hip and Knee Arthroplasty
Presented by
Learn how the LEGION MS + CORI Digital Tensioner optimizes knee alignment and how the best in class just got better for hips with the combination of CATALYSTEM and CORIOGRAPH
SPEAKERS: George J. Haidukewych, MD, Ran Schwarzkopf, MD
INDUSTRY SPOTLIGHT SESSIONS (NON-CME)
FRIDAY, FEBRUARY 6 | 5:35 - 6:00 PM
A Simplified Hip Revision Experiene with Mako Total Hip
Presented by
Join to experience the next evolution in robotic-assisted hip revision surgery using the Mako Total Hip Advance Primary and Revision software through the Direct Anterior Approach.
SPEAKER: Elizabeth B. Gausden, MD, David J. Mayman, MD
Presented by SATURDAY, FEBRUARY 7 | 8:05 - 8:30 AM
Advances and Insights in Surgical Wound Closure
MODERATOR: Roshan P. Shah, MD, JD
PANEL: Eizabeth B. Gausden, MD, Jeremy M. Gililland,MD, David J. Mayman, MD, Ormonde M. Mahoney, MD, Mark J. Spangehl, MD, Ran Schwarzkopf, MD
Network:JAMM2026
Password:HipKnee!
THURSDAY - FEBRUARY 5, 2026
DAILY SCHEDULE
JAMM 2026 | February 5-8 Grand Hyatt Deer Valley, Park City, UT
1:00-5:00pm ATTENDEE CHECK-IN Jordanelle Ballroom Foyer
4:30-4:35pm Jordanelle Ballroom Fred D. Cushner, MD
SESSION I
4:35-4:50pm
Jordanelle Ballroom
Moderator: Richard W. McCalden, MD
4:35-4:40pm Pro Jeremy M. Gililland, MD
4:40-4:45pm Con Christopher L. Peters, MD
4:45-4:50pm Discussion
SESSION II
4:50-5:05pm
Moderator: Neil P. Sheth, MD
4:50-4:55pm Most of My Hips Are Outpatient Matthew S. Austin, MD
4:55-5:00pm I Still Keep Patients Overnight James D. Slover, MD
5:00-5:05pm Discussion
SESSION III CHALLENGING CASES WITH MODERATORS
6:00- 6:30pm
Moderators: Henry D. Clarke, MD, George J. Haidukewych, MD Hip Cases Knee Cases
7:00-8:00pm
WELCOME
FRIDAY - FEBRUARY 6, 2026
6:00-6:45am
6:50-6:55am
6:55-7:00am
SESSION V CASE PRESENTATIONS
7:00-7:30am
7:00-7:10am PFJ Case
7:10-7:20am Medial and Patella DJD? Bicompartmental
Jordanelle Ballroom
Moderator: Christopher L. Peters, MD
Christopher E. Pelt, MD
David J. Mayman, MD
7:20-7:30am Painful UKA- When and How to Revise Cynthia Kahlenberg, MD
SESSION VI DEBATES
7:30-8:15am
UKA
7:30-7:35am UKA is Underutilized
Jordanelle Ballroom
Moderator: Fred D. Cushner, MD
Christopher A. F. Dodd, FRCS
7:35-7:40am UKA Not Often Needed Wayne G. Paprosky, MD
7:40-7:45am Discussion
ROBOTS AND UKA
7:45-7:50am Robots Not Required for Good Results
7:50-7:55am UKA Should be Done With a Robot
7:55-8:00am Discussion
PF DJD AND UKA – HOW MUCH IS TOO MUCH?
8:00-8:05am You Can (Mostly) Ignore the Patella
8:05 -8:10am TKA if Patella DJD Present
8:10-8:15am Discussion
8:20-8:45am
NON-CME INDUSTRY SPOTLIGHT PRESENTED BY: Smith+Nephew
Christopher A. F. Dodd, FRCS
Mark W. Pagnano, MD
Cynthia Kahlenberg, MD
Douglas D.R. Naudie, MD
Deer Creek Ballroom A
The Robotic Knee Revolution + DA360: Edcuation to Outcomes: George J. Haidukewych, MD Personalized Solutions for Hip and Knee Arthroplasty Ran Schwarzkopf, MD
SESSION VII UNCEMENTED TKA
8:50-9:55am
8:50-9:00am Criteria for Uncemented TKA
9:00-9:10am Uncemented TKA and the Obese Patient
9:10-9:20am Uncemented Patella is the Key
9:20-9:30am Uncemented UKA
9:30-9:40am Infection and the UKA
9:40-9:55am Discussion
9:55-10:25am MORNING BREAK WITH EXHIBITORS
SESSION VIII PERIPROSTHETIC HIP FRACTURE
10:25-11:30am
DEBATE: STEM CHOICE MAKES A DIFFERENCE IN FRACTURE RATE
10:25-10:30am The Triple Taper Reduces Periprosthetic Fracture Risk
10:30-10:35am There is Still a Role for Blade Stems
10:35-10:40am Cement in Certain Situations Makes the Most Sense
10:40-10:45am Discussion
DIDACTIC TALKS
10:45-10:52am How to Manage the Intraoperative Calcar Fracture During DAA
10:52-10:59am How to Manage the Early B2 Fracture
10:59-11:06am How to Manage Vancouver C and Other Complex
Periprosthetic Fractures
11:06-11:13am DA Revision Tips and Tricks for Fracture and Other Revisions
11:13-11:20am Posterior Approach Tips and Tricks for Fracture and
Jordanelle Ballroom
Moderator: Geoffrey H. Westrich, MD
David C. Markel, MD
Ronald E. Delanois, MD
Fred D. Cushner, MD
Christopher A. F. Dodd, FRCS
Henry D. Clarke, MD
Jordanelle Ballroom A-B
Jordanelle Ballroom
Moderator: Matthew S. Austin, MD
Michael J. Archibeck, MD
P. Maxwell Courtney, MD
Richard W. McCalden, MD
Christopher E. Pelt, MD
John Antoniou, MD
George J. Haidukewych, MD
Jeremy M. Gililland, MD
Samuel S. Wellman, MD Other Revisions
11:20-11:30am Discussion
11:30-4:00pm AFTERNOON BREAK | PLEASE RETURN ON TIME
4:00-4:30pm
APRÈS SKI | REFRESHMENTS WITH EXHIBITORS
SESSION IX HIP CASES AND TABLE DISCUSSIONS
4:30-5:30pm
4:30-4:40pm THA in Patient S/P ORIF Acetabular FX
4:40-4:50pm THA in Crowe III–IV DDH
4:50-5:00pm THA in Patient with Failed Femoral ORIF
Jordanelle Ballroom A-B
Jordanelle Ballroom
Moderator: John Antoniou, MD
Elizabeth B. Gausden, MD
James L. Howard, MD
George J. Haidukewych, MD
5:00-5:10pm THA in Patient with Femoral Deformity John Antoniou, MD
4:30-5:35pm THA in Little People Wayne G. Paprosky, MD
5:20-5:30pm Video-Based: THA in 85-Year-Old Osteopenic Female –
Richard W. McCalden, MD How to Cement a Femoral Stem
NON-CME INDUSTRY SPOTLIGHT PRESENTED BY: Stryker
5:35-6:00pm
A Simplified Hip Revision Experience with Mako Total Hip
SESSION X COMPLEX PRIMARY KNEES – CASES AND TABLE DISCUSSIONS
6:05-7:15pm
Deer Creek Ballroom A
Elizabeth B. Gausden, MD
David J. Mayman, MD
Jordanelle Ballroom
Moderator: Fred D. Cushner, MD
6:05-6:15pm BMI 50 Fred D. Cushner, MD
6:15-6:25pm Retained Hardware
6:25-6:35pm Stiff Knee
Ormonde M. Mahoney, MD
James D. Slover, MD
6:35-6:45pm Video-Based: Severe Valgus Henry D. Clarke, MD
6:45-6:55pm Video-Based: Severe Varus
6:55-7:05pm Extraarticular Deformity
7:05-7:15pm Operation Walk: Getting More By Giving Back
SATURDAY - FEBRUARY 7, 2026
6:00-6:45am BREAKFAST WITH EXHIBITORS
DAY 3: WELCOME | ANNOUCEMENTS
6:45am
SESSION XI BEARING SURFACES IN TKA
6:45 – 7:00am
6:45-6:50am MC Bearing is Here and PS is Obsolete
Eric L. Smith, MD
David C. Markel, MD
Matthew S. Austin, MD
Jordanelle Ballroom A-B
Jordanelle Ballroom
Christopher L. Peters, MD
Jordanelle Ballroom
Moderator: Matthew S. Austin, MD
James L. Howard, MD
6:50-6:55am PS Bearing Remains More Appropriate When PCL is Sacrificed Cynthia Kahlenberg, MD
6:55-7:00am Discussion
SESSION XII CONTEMPORARY ISSUES IN PERIOPERATIVE CARE
7:00-8:00am
7:00-7:07am 30 Year Experience with Cementless TKA
7:07-7:14am Wound Care Advancements in TJA and Prevention of Wound
Jordanelle Ballroom
Moderator: Ronald E. Delanois, MD
Aaron A. Hofmann, MD
Roshan P. Shah, MD Healing Issues With DAA
7:14-7:21am Patient Engagement Platforms Can Enhance Your Practice
7:21-7:28am Wound Closure 2026: What We Have Learned
7:28-7:35am Outpatient TJA Experience in a Tertiary Hospital Environment
7:35-7:42am What Did We Learn from the Latest International Consensus
Christopher L. Peters, MD
David J. Mayman, MD
Christopher E. Pelt, MD
Mark J. Spangehl, MD Meeting on Infection?
7:42-7:49am Perioperative Care: What Does the Evidence Say about BMI,
Edward M. Vasarhelyi, MD Smoking, Diabetes and Other Modifiable Risk Factors
7:49-8:00am Discussion
8:05-8:30am
NON-CME INDUSTRY SPOTLIGHT PRESENTED BY: Sylke
Advances and Insights in Surgical Wound Closure
SESSION XIII PRIMARY TKA
8:35-9:30am
Deer Creek Ballroom A
Moderator: Roshan P. Shah, MD, JD Panel:
Elizabeth B. Gausden, MD,Jeremy M. Gililland,MD, David J. Mayman, MD
Ormonde M. Mahoney, MD, Mark J. Spangehl, MD, Ran Schwarzkopf, MD
8:35-8:40am Personalized Alignment Has Revolutionized TKA
8:40-8:45am I prefer Image Based Robotics
8:45-8:50am No Image Needed for My Robot
8:50-8:55am I Still Like My Tourniquet
8:55-9:00am Time to Change- No Tourniquet Needed
9:00-9:05am Wound Closure/Wound Management 2026
9:05-9:10am Perioperative Medication Update: What I Use and Why
9:10-9:15am GLP-1's and the Arthroplasty Patient
9:15-9:30am Update on Dental Prophylaxis- What is Really Needed
9:30-10:30am MORNING BREAK WITH EXHIBITORS
SESSION XIV PRIMARY THA
10:00-11:30am
10:00-10:08am Direct Anterior THA with Fluoro Guidance
10:08-10:16am Anterior Based Muscle Sparing Approach with Low Tech
10:16-10:24am Posterior Approach with Robotic Assistance
Jordanelle Ballroom
Moderator: Mark W. Pagnano, MD
Henry D. Clarke, MD
David J. Mayman, MD
Christopher L. Peters, MD
Matthew S. Austin, MD
Ronald E. Delanois, MD
Elizabeth B. Gausden, MD
Neil P. Sheth, MD
Mark J. Spangehl, MD
Ormonde M. Mahoney, MD
Jordanelle Ballroom A-B
Jordanelle Ballroom
Moderator: James D. Slover, MD
Jeremy M. Gililland, MD
Ronald E. Delanois, MD
David J. Mayman, MD
10:24-10:32am The French Paradox Concept for Cemented Stems Ran Schwarzkopf, MD
10:32-10:40am Wagner Cone for Challenging Primaries
10:40-10:48am The Cementless Collared Tri-Taper Stem is the Only Way to Go!
10:48-10:56am AR/VR Technology for Primary THA
10:56-11:04am Acetabular Cup Primer – From Routine to Complex
11:04-11:12am Ceramic on Highly Cross-Linked Polyethylene is the Only
James L. Howard, MD
Mark W. Pagnano, MD
Michael J. Taunton, MD
Douglas D.R. Naudie, MD
Ran Schwarzkopf, MD Couple to Consider 11:12-11:20am Dual-Mobility Bearings Make Sense for Most Primaries
11:20-11:30am Discussion
11:30-4:00pm AFTERNOON BREAK | PLEASE RETURN ON TIME
4:00-4:30pm APRÈS SKI | REFRESHMENTS WITH EXHIBITORS
SESSION XV REVISION THA: CASE PRESENTATIONS AND TABLE DISCUSSIONS
4:30-5:40pm
4:30-4:40pm Revising the Loose Cementless Femoral Component
4:40-4:50pm Revising the Loose Cemented Femoral Component
4:50-5:00pm Revising the Recurrent Dislocator
5:00-5:10pm Revising for Taper Corrosion
5:10-5:20pm Revising for Pelvic Discontinuity
5:20-5:30pm ORIF vs. Revising for Periprosthetic Femoral Fracture
5:30-5:40pm How I Do an Antibiotic Loaded Spacer for Infected THA
Neil P. Sheth, MD
Jordanelle Ballroom A-B
Jordanelle Ballroom
Moderator: David J. Mayman, MD
Michael J. Taunton, MD
John Antoniou, MD
Edward M. Vasarhelyi, MD
Douglas D.R. Naudie, MD
Neil P. Sheth, MD
David C. Markel, MD
Ran Schwarzkopf, MD
SESSION XVI REVISION TKA: CASE PRESENTATIONS AND TABLE DISCUSSIONS
5:40-6:40pm
5:40-5:50pm Conversion of a Failed Uni
5:50-6:00pm ORIF or Revision for Periprosthetic Fracture
6:00-6:10pm Revision for Instability
6:10-6:20pm Revision for Aseptic Loosing with Collapse and Bone Loss
Jordanelle Ballroom
Moderator: Christopher A. F. Dodd, FRCS
Christopher A. F. Dodd, FRCS
Elizabeth B. Gausden, MD
Matthew S. Austin, MD
Geoffrey H. Westrich, MD
6:20-6:30pm Revision for Stiffness Samuel Wellman, MD
6:30-6:40pm Looks Good but Feels Bad Eric L. Smith, MD
SUNDAY - FEBRUARY 8, 2026
6:00-6:45am
6:45am
BREAKFAST WITH EXHIBITORS
DAY 4: WELCOME | ANNOUCEMENTS
SESSION XVII DEBATE:
6:45 – 7:05am
Jordanelle Ballroom A-B
Jordanelle Ballroom
Christopher L. Peters, MD
Jordanelle Ballroom
Moderator: Christopher E. Pelt, MD
6:45-6:50am One Stage Eric L. Smith, MD
6:50-6:55am Two Stage Samuel Wellman, MD
6:55-7:00am 1.5 Stage
7:00-7:05am Discussion
SESSION XVIII REVISION TKA
7:05-8:00am
7:05-7:13am Tips on Exposure for Revision
7:13-7:23am Video-Based: How to Remove the Prosthesis and Save Bone
Jeremy M. Gililland, MD
Jordanelle Ballroom
Moderator: Ormonde M. Mahoney, MD
Matthew S. Austin, MD
Geoffrey H. Westrich, MD
7:23-7:31am I Prefer Cones with Cemented Stems Ran Schwarzkopf, MD
7:31-7:39am I Prefer Cones with Cementless Stem Fixation
7:39-7:47am How to Do the Revision with Cemented Stems in Place
P. Maxwell Courtney, MD
Roshan P. Shah, MD, JD
7:47-7:55am How Much Constraint Do I Need? Ormonde M. Mahoney, MD
7:55-8:00am Discussion
SESSION XIX REVISION HIP
8:00-9:00am
8:00-8:08am Tips for Successful Extended Trochanteric Osteotomy
8:08-8:16am Tips for Successful Wagner Osteotomy
8:16-8:24am Acetabular Revision: Ultra-Porous Cups, Augments, Cages
8:24-8:32am Custom Tri-flange Makes Revision Easier
8:32-8:40am I Prefer Modular Monoblock Titanium Tapered Splined Stems
8:40-8:48am I Prefer Modular Titanium Tapered Splined Stems
8:48-9:00am Discussion
9:00-9:30am
MORNING BREAK WITH EXHIBITORS
SESSION XX COMPLEX CASE PRESENTATIONS
9:30-10:30am
9:30-9:40am Complex Case
9:40-9:50am Complex Case
9:50-10:00am Complex Case
10:10-10:10am Complex Case
10:10-10:20am Complex Case
10:20-10:30am Closing Remarks / Final Questions for Faculty
10:30am ADJOURN
Jordanelle Ballroom
Moderator: P. Maxwell Courtney, MD
Wayne G. Paprosky, MD
Michael J. Taunton, MD
P. Maxwell Courtney, MD
James D. Slover, MD
Richard W. McCalden, MD
Michael J. Archibeck, MD
Jordanelle Ballroom A-B
Jordanelle Ballroom
Moderator: Michael J. Archibeck, MD
Roshan P. Shah, MD, JD
Edward M. Vasarhelyi, MD
Cynthia Kahlenberg, MD
Mark Spangehl, MD
Fred D. Cushner, MD
THE HIP SOCIETY AND THE KNEE SOCIETY THANK THE FOLLOWING COMPANIES FOR THEIR SUPPORT OF JAMM® 2026 THROUGH
SPONSORSHIPS AND EXHIBITS
We encourage all participants and faculty to visit and interact with our exhibitors during designated unopposed exhibit times.
INDUSTRY PARTNERS
DePuy Synthes – Exhibit Space 14 EXHIBITORS
Arthro-Positioning Systems - Exhibit Space 6
www.arthropositioningsystems.com
Arthro-Positioning Systems is devoted to making positioning the body for surgery as simple, intuitive, and effective as possible. Our device, the Velocity Bump, eliminates the need for costly and time-consuming sterile processing and allows clinicians to put the joint Where they want it, When they want it.
Bone Support – Exhibit Space 8
www.bonesupport.com/en-us/
BONESUPPORT is advancing bone infection management for Arthroplasty, Trauma and Foot & Ankle surgeons. We are an orthobiologics company and the maker CERAMENT® G with Gentamicin, the only FDA authorized bone remodeling technology that is injectable and elutes antibiotics. Our products are effective in treating patients with fractures and bone voids caused by trauma, infection, disease or related surgery.
Decipthera – Exhibit Space 7
www.deciphera.com
We are a commercial-stage biopharmaceutical company on a mission to deliver transformational medicines to patients. Headquartered in Waltham, MA with research facilities in Lawrence, KS, we develop innovative science to provide hope to people living with cancer.”
www.jnjmedtech.com/en-US/companies/depuy-synthes
DePuy Synthes provides one of the most comprehensive orthopaedics portfolios in the world that helps heal and restore movement for the millions of patients we serve. DePuy Synthes solutions, in specialties including joint reconstruction, trauma, extremities, craniomaxillofacial, spinal surgery and sports medicine, in addition to the VELYS™ Enabling Tech portfolio, are designed to advance patient care while delivering clinical and economic value.
Innomed - Exhibit Space 6
www.innomed.net
Innomed, Inc., a developer of instruments for orthopedic surgery, continues to introduce new and innovative products. We offer an array of unique instruments and patient positioning devices, designed by or in conjunction with orthopedic surgeons and surgical professionals.
Medacta – Exhibit Space 9
www.medacta.us.com
Medacta is specialized in the design, production, and distribution of innovative orthopedic products and surgical techniques, supporting surgeons with comprehensive and tailored programs of medical education. Medacta is committed to improving the care and well-being of patients focusing on healthcare sustainability. Medacta’s innovation, forged by close collaboration with expert surgeons, began with minimally invasive techniques and has evolved into personalized solutions for every patient.
OrthAlign, Inc. – Exhibit Space 12
www.orthalign.com
OrthAlign is driven by the belief that everyone deserves exceptional health care. Our technology provides surgeons with live navigation in knee & hip replacements in any OR with any implant
Smith+Nephew – Exhibit Spaces 10-11
www.jnjmedtech.com/en-US/companies/depuy-synthes
Smith+Nephew is a global medical technology business with global leadership positions in Orthopaedic Reconstruction, Sports Medicine, Trauma Fixation, Extremities & Limb Restoration, and Advanced Wound Management. Visit www.smith-nephew.com for more information.
SpringWorks – Exhibit Space 5
www.springworkstx.com
Sylke – Exhibit Space 13
www.sylke.com
SYLKE® was launched in December 2023 to provide a safer solution to the complications caused by synthetic wound dressings. Made from 99.9999% silk fibroin—a natural, nonimmunogenic protein renowned for its strength, flexibility, and biocompatibility—SYLKE® serves as both a closure device and dressing. It protects wounds, manages exudate, and mimics skin elasticity to improve comfort and patient outcomes, making it an ideal choice for surgical incisions, emergency lacerations, and at-home care.
TJO Inc.– Exhibit Space 4
www.tjoinc.com
TJO is committed to bringing innovation to orthopedics. TJO is surgeon-founded and surgeon-focused, and every implant and instrument is designed with the user in mind. A combination of intelligent engineering and direct user feedback has led to an intuitive, consistent experience resulting in exceptional patient outcomes. Please stop by our table to learn how TJO can improve your workflow and the surgical experience for patients and staff.
Zimmer Biomet – Exhibit Spaces 2-3
www.ZimmerBiomet.com
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.
